1Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren′s syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis, 2002,61:554-558. 被引量：1
2Powell FC, Winkelmann RK, Venencie-Lemarchand F, et al. The anticentromere antibody: disease specificity and clinical significance. Mayo Clin Proc,1984 ,59:700-705. 被引量：1
3Katato K, Kawano M, Koni I, et al. Clinical and laboratory features of anticentromere antibody positive primary Sjogren′s syndrome. J Rheumatol, 2001,28:2238-2244. 被引量：1
4Whyte J, Hough D, Maddison PJ, et al. The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. J Autoimmun, 1994 ,7:413-424. 被引量：1
7Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis ,2002,61:554-558. 被引量：1
8Vlachoyiannopoulos PG, Drosos AA, Wiik A, et al. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol, 1993,32:297-301. 被引量：1
9Ramos-Casals M, Nardi N, Brito-Zeron P, et al. Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum, 2006,35:312-321. 被引量：1
10Gelber AC, Pillemer SR, Baum BJ, et al. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma. Ann Rheum Dis, 2006,65: 1028-1032. 被引量：1
